Anatara Lifesciences (ASX:ANR) Interest Expense : A$-0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Anatara Lifesciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Anatara Lifesciences's interest expense for the six months ended in Dec. 2023 was A$ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Anatara Lifesciences's Operating Income for the six months ended in Dec. 2023 was A$ -0.96 Mil. Anatara Lifesciences's Interest Expense for the six months ended in Dec. 2023 was A$ 0.00 Mil. Anatara Lifesciences has no long-term debt ⁽¹⁾. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Anatara Lifesciences Interest Expense Historical Data

The historical data trend for Anatara Lifesciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anatara Lifesciences Interest Expense Chart

Anatara Lifesciences Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Interest Expense

Get a 7-Day Free Trial

Anatara Lifesciences Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial														-	-	-	-	-

Anatara Lifesciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.00 Mil.

Anatara Lifesciences (ASX:ANR) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Anatara Lifesciences's Interest Expense for the six months ended in Dec. 2023 was A$0.00 Mil. Its Operating Income for the six months ended in Dec. 2023 was A$-0.96 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was A$0.00 Mil.

Anatara Lifesciences's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Anatara Lifesciences had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Anatara Lifesciences (ASX:ANR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anatara Lifesciences Ltd (ASX:ANR) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/- Perks, 81 Flinders Street, Level 8, Adelaide, SA, AUS, 5000

Website

https://www.anataralifesciences.com

Anatara Lifesciences Ltd is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Its products include the Gastrointestinal ReProgramming dietary supplement (GaRP) for humans and Detach for animals. It generates its income from license revenue.

Anatara Lifesciences (ASX:ANR) Headlines

No Headlines